Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.3 USD | -8.21% | -13.38% | +17.53% |
May. 28 | Sarepta Therapeutics Shares Fall After RBC Downgrade | MT |
May. 28 | RBC Downgrades Sarepta Therapeutics to Sector Perform From Outperform, Lowers Price Target to $142 From $157 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.53% | 11.67B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
-30.73% | 7.55B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Oppenheimer Upgrades Sarepta Therapeutics to Outperform From Perform, Price Target is $180